BACKGROUND Ebola Virus Disease (Ebola) is a viral hemorrhagic fever that causes severe illness and can be fatal. Symptoms present 2 to 21 days after exposure to the Ebola virus and include: sudden onset of fever, severe headache, muscle pain, weakness, and fatigue, followed by vomiting, diarrhea, abdominal pain and unexplained bleeding or bruising.1 In December 2013, an outbreak of Ebola began ...

626 www.thelancet.com/infection Vol 15 June 2015 6 Bellan SE, Pulliam JRC, Pearson CAB, et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis 2015; published online April 15. http://dx.doi. org/10.1016/S1473-3099(15)70139-8. 7 The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group. Can...

BACKGROUND During the 2014-2016 West Africa Ebola Virus Disease (EVD) epidemic, the public health community had concerns that sexual transmission of the Ebola virus (EBOV) from EVD survivors was a risk, due to EBOV persistence in body fluids of EVD survivors, particularly semen. The Sierra Leone Ebola Virus Persistence Study was initiated to investigate this risk by assessing EBOV persistence i...

As of October 31, 2014, the Sierra Leone Ministry of Health and Sanitation had reported 3,854 laboratory-confirmed cases of Ebola virus disease (Ebola) since the outbreak began in May 2014; 199 (5.2%) of these cases were among health care workers. Ebola infection prevention and control (IPC) measures are essential to interrupt Ebola virus transmission and protect the health workforce, a populat...

With over 4,500 deaths and counting, and new cases identified in two developed countries that are struggling and faltering in their handling of the epidemic, the 2014 Ebola Virus Disease (EVD) epidemic is unlike any of its kind ever encountered. The ability of some poor, resource-limited, developing countries in sub-Saharan Africa to efficiently handle the epidemic within their shores provides ...

Health research programs targeting the population of Gabon and Equatorial Africa at the International Center for Medical Research in Franceville (CIRMF), Gabon, have evolved during the years since its inception in 1979 in accordance with emerging diseases. Since the reemergence of Ebola virus in Central Africa, the CIRMF "Emerging Viral Disease Unit" developed diagnostic tools and epidemiologic...

background: the emergence and spread of ebola outbreak is a growing problem worldwide, which represents a significant threat to public health. evidence has shown that the level of knowledge, attitude, and practice of people in the society play major roles in controlling the spread of ebola virus disease. this study was designed to determine knowledge, attitude and practice of students at school...

OBJECTIVE This study aimed to identify predictors of health-related quality of life (HrQoL) and to investigate infection-related concerns in health professionals during the acute treatment episode for one Ebola virus disease (EVD) patient in tertiary care. METHODS In a cross-sectional controlled study, validated self-report questionnaires were completed by three groups of health care professi...

OBJECTIVE To conduct assessments of Ebola virus disease preparedness in countries of the World Health Organization (WHO) South-East Asia Region. METHODS Nine of 11 countries in the region agreed to be assessed. During February to November 2015 a joint team from WHO and ministries of health conducted 4-5 day missions to Bangladesh, Bhutan, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thaila...

The current outbreak of Ebola virus disease in West Africa is the worst so far. The unprecedented extent of mortality and morbidity in this outbreak has followed more from imposition of neoliberal economic policies on the countries affected than from the biological virulence of Ebola virus. The lack of vaccines and medications for Ebola virus disease is evidence that markets cannot reliably sup...